Core Viewpoint - The launch of the EVO ICL (V5) crystal implantation surgery in Gansu marks the introduction of a cutting-edge myopia correction technology, allowing local patients to access advanced treatment without traveling abroad [2][3]. Group 1: Technology and Innovation - The EVO ICL V5 crystal features a key advancement with an optical zone diameter increased from 5.8 mm to 6.1 mm, significantly enhancing night vision quality for patients, especially those with larger pupils, and reducing glare and halos [2]. - The V5 crystal improves the correction precision for moderate to low myopia to a range of 25 degrees, promoting personalized treatment options [2]. - The crystal has high biocompatibility and UV-blocking capabilities, having undergone over 30 years of clinical validation globally, making it a reliable surgical choice due to its non-cutting, safe, and reversible nature [2]. Group 2: Clinical Implementation and Recognition - The V5 technology's regular implementation in Lanzhou signifies its official approval by national authorities, allowing patients in Gansu and the northwest region to benefit from this advanced technology locally [3]. - A plaque ceremony was held to establish the "EVO ICL V5 Crystal Gansu Clinical Application Popularization Alliance," highlighting the collaboration between STAAR company and local hospitals, along with the certification of the first surgical expert in Gansu [3][5]. Group 3: Safety and Patient Experience - The V5 crystal maintains the safety foundation of its predecessor, with innovations primarily in optical design, supported by over 40 precise preoperative examinations to ensure safety and effectiveness [5]. - Different myopia correction techniques cater to various needs, with the EVO ICL (V5) particularly suited for patients with high myopia (over 600 degrees) and those requiring enhanced night vision, such as drivers [5]. - Patient testimonials shared during the event highlighted improvements in night vision and overall quality of life, resonating with the audience [5]. Group 4: Future Directions - The Lanzhou Eye Hospital plans to continue introducing global innovative technologies, ensuring a comprehensive range of surgical options and strict quality control to provide safer, more precise, and personalized visual quality enhancement solutions for patients in the northwest region [5].